Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Odyssey Therapeutics, Inc.Startup |
Active Organization Odyssey Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blau Syndrome | Phase 1 | AU | Odyssey Therapeutics, Inc.Startup | 12 Feb 2024 |
Colitis, Ulcerative | Phase 1 | AU | Odyssey Therapeutics, Inc.Startup | 12 Feb 2024 |
Crohn Disease | Phase 1 | AU | Odyssey Therapeutics, Inc.Startup | 12 Feb 2024 |
Spondylarthritis | Phase 1 | AU | Odyssey Therapeutics, Inc.Startup | 12 Feb 2024 |